Clinical Trials Directory

Trials / Completed

CompletedNCT02538120

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to see whether or not the diabetes 1 patients have a neurovascular microcirculatory dysfunction using various microvascular tests which have been previously validated. Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).

Detailed description

The investigators will compare microvascular responses between diabetes type 1 patients with matched control-subjects.

Conditions

Interventions

TypeNameDescription
OTHERMicrovascular assessmentMicrovascular assessment

Timeline

Start date
2012-05-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2015-09-02
Last updated
2016-02-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02538120. Inclusion in this directory is not an endorsement.

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients (NCT02538120) · Clinical Trials Directory